How did Thermo Fisher's revenue and expenses trend in Q4 2024?

Thermo Fisher's revenue and expenses in Q4 2024 showed distinct trends:

1. **Revenue Trend**: Thermo Fisher's total revenue for Q4 2024 was $11.4 billion. This is a notable figure considering the company's business segments, with Laboratory Products and Services contributing the most at $23.16 billion, followed by Life Sciences Solutions at $17.22 billion, and Analytical Instruments at $9.63 billion. The company's focus on strategic acquisitions and partnerships, especially in the bioproduction space, has been a key driver of revenue growth.

|code|Ticker|Name|Date|Business Composition|Revenue By Business|market_code|
|---|---|---|---|---|---|---|
|TMO|TMO.N|Thermo Fisher|20240101-2024|Eliminations|-1.885E9|169|
|TMO|TMO.N|Thermo Fisher|20240101-2024|Eliminations|-1.397E9|169|
|TMO|TMO.N|Thermo Fisher|20240101-2024|Eliminations|-9.3E8|169|
|TMO|TMO.N|Thermo Fisher|20240101-2024|Specialty Diagnostics|1.109E9|169|
|TMO|TMO.N|Thermo Fisher|20240101-2024|Laboratory Products and Services|5.723E9|169|
|TMO|TMO.N|Thermo Fisher|20240101-2024|Analytical Instruments|1.687E9|169|
|TMO|TMO.N|Thermo Fisher|20240101-2024|Life Sciences Solutions|2.285E9|169|
|TMO|TMO.N|Thermo Fisher|20240101-2024|Eliminations|-4.6E8|169|
|TMO|TMO.N|Thermo Fisher|20240101-2024|Specialty Diagnostics|1.109E9|169|

2. **Expense Trend**: Net income for the quarter was $1.82 billion, indicating a strong profitability period despite the challenges posed by macroeconomic issues and currency fluctuations. The company's R&D expenses were $374 million, which, although significant, are relatively small compared to the overall revenue, suggesting an efficient use of resources for innovation. General and Administrative expenses stood at $2.28 billion, which, when compared to the revenue, reflect the company's substantial investment in administrative functions to support its business growth.

|code|Ticker|Name|Date|Net Income YoY|Net Income|market_code|
|---|---|---|---|---|---|---|
|TMO|TMO.N|Thermo Fisher|2024 Q1|3.018575851393189|1.331E9|169|
|TMO|TMO.N|Thermo Fisher|2024 Q2|14.023494860499266|1.553E9|169|
|TMO|TMO.N|Thermo Fisher|2024 Q3|-3.893805309734513|1.629E9|169|
|TMO|TMO.N|Thermo Fisher|2024 Q4|13.57409713574097|1.824E9|169|

|code|Ticker|Name|Date|R&D Expenses|R&D Expenses YoY|market_code|
|---|---|---|---|---|---|---|
|TMO|TMO.N|Thermo Fisher|2024 Q1|3.31E8|-4.335260115606936|169|
|TMO|TMO.N|Thermo Fisher|2024 Q2|3.39E8|-1.7391304347826086|169|
|TMO|TMO.N|Thermo Fisher|2024 Q3|3.46E8|8.463949843260188|169|
|TMO|TMO.N|Thermo Fisher|2024 Q4|3.74E8|14.37308868501529|169|

|code|Ticker|Name|Date|Selling, General, and Administrative Expenses|Selling, General, and Administrative Expenses YoY|market_code|
|---|---|---|---|---|---|---|
|TMO|TMO.N|Thermo Fisher|20240331|2.282E9|1.3321492007104796|169|
|TMO|TMO.N|Thermo Fisher|20240630|2.111E9|-1.5850815850815851|169|
|TMO|TMO.N|Thermo Fisher|20240930|2.098E9|2.3914104441190824|169|
|TMO|TMO.N|Thermo Fisher|20241231|2.284E9|2.192393736017897|169|

3. **Sales and Marketing Expenses**: Specific data for sales and marketing expenses in Q4 2024 is not available. However, the company's overall performance and the fact that it has successfully executed its disciplined capital deployment strategy suggest that while these expenses are crucial, they are likely to be managed effectively to support the overall growth objectives.

In conclusion, Thermo Fisher's Q4 2024 financials reflect a company that is not only growing its top line through strategic acquisitions and market expansions but also managing its expenses, including R&D and G&A, to maintain a healthy bottom line. The absence of specific data for sales and marketing expenses does not detract from the overall picture of a financially robust and strategically focused company.